Vadim Mett

USPTO Granted Patents = 22 (Patent Applications = 9)

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 5)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 58(Granted Patents)

Location History:

Newark, DE (US) (2010 - 2016)
Elma, NY (US) (2015 - 2017)
Buffalo, NY (US) (2019 - 2023)

Company Filing History:

Genome Protection, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2023

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542306 - Flagellin-based agents and uses including effective vaccination (2023-01-03),

2. 11034733 - Flagellin compositions and uses (2021-06-15),

3. 10975127 - Flagellin-based agents and uses including effective vaccination (2021-04-13),

4. 10730915 - Flagellin-based agents and uses including effective vaccination (2020-08-04),

5. 10669316 - Flagellin compositions and uses (2020-06-02),

6. 10336793 - Flagellin-based agents and uses including effective vaccination (2019-07-02),

7. 10202426 - Flagellin compositions and uses (2019-02-12),

8. 9809644 - Influenza hemagglutinin antibodies, compositions and related methods (2017-11-07),

9. 9498513 - Antimicrobial bacteria strains and uses thereof (2016-11-22),

10. 9156893 - Antimicrobial bacteria strains and uses thereof (2015-10-13),

11. 9115201 - Humanized neuraminidase antibody and methods of use thereof (2015-08-25),

12. 9012199 - Recombinant carrier molecule for expression, delivery and purification of target polypeptides (2015-04-21),

13. 8962278 - Compositions and methods for production of immunoglobulins (2015-02-24),

14. 8945580 - [object Object] (2015-02-03),

15. 8784819 - Influenza hemagglutinin antibodies, compositions and related methods (2014-07-22),

Title: The Innovative Contributions of Vadim Mett

Introduction

Vadim Mett is a prominent inventor based in Newark, DE (US), known for his significant contributions to the field of biotechnology. With a remarkable portfolio of 22 patents, Mett has made strides in developing innovative solutions for vaccination and disease treatment.

Latest Patents

Among his latest patents, Mett has developed "Flagellin-based agents and uses including effective vaccination." This invention relates to compositions comprising improved flagellin derived constructs and methods of using them for vaccination, including adjuvants comprising flagellin-based agents. Another notable patent is "Flagellin compositions and uses," which focuses on compositions comprising improved flagellin derived constructs and methods for treating various diseases.

Career Highlights

Throughout his career, Vadim Mett has worked with notable companies such as Ibio Limited and Fraunhofer USA, Inc. His work has been instrumental in advancing the understanding and application of flagellin in medical treatments.

Collaborations

Mett has collaborated with esteemed colleagues, including Vidadi Yusibov and Konstantin Musiychuk, further enhancing the impact of his research and innovations.

Conclusion

Vadim Mett's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in vaccination and disease treatment.

This text is generated by artificial intelligence and may not be accurate.